In vivo inhibition of TNFalpha-induced vascular permeability by resveratrol.
Fulgenzi
A
A
Nuclear Medicine Department, IRCCS Ospedale Maggiore Policlinico, Milan, Italy.
Bertelli
A A
AA
Magni
E
E
Ferrero
E
E
Ferrero
M E
ME
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects* / Q000502:physiology; D008099:Liver / Q000098:blood supply; D008102:Liver Circulation / Q000187:drug effects* / Q000502:physiology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011994:Recombinant Proteins; D013267:Stilbenes; D014409:Tumor Necrosis Factor-alpha; D000077185:Resveratrol